ViMUT Hospital ready to provide jabs for 20,000 Chinese expats
Bangkok’s ViMUT Hospital is collaborating with the Chinese embassy to provide Covid-19 jabs for Chinese nationals living in Thailand.
The hospital said it delivered jabs to people working for Huawei Technologies (Thailand) on May 21 and aims to vaccinate at least 20,000 Chinese nationals as part of the inoculation drive.
It will also work with other embassies interested in providing vaccinations for their nationals from June 7 onwards.
The hospital is also getting ready to provide the second jab for medical personnel in the Bangkok metropolitan area. Senior citizens and those with chronic conditions as well as the general public will receive their first dose in line with the schedule set up by the government.
People can book their vaccination via the “Mor Prom” Line account, while those wishing to have a health check-up to assess their readiness for the jab or related medical advice can visit the hospital in person.
ViMUT Hospital is on Phaholyothin road and can be accessed via the Saphan Khwai or Ari BTS stations.
People can also call (02) 079 0000 or direct their queries to ViMUT Hospital’s Facebook page or official Line account.
CDC probes rare cases of heart inflammation in vaccinated teens, young adults
Vaccine safety experts are studying a small number of cases of heart muscle inflammation that have been reported in multiple countries among young people who had recently received their second dose of one of the coronavirus vaccines.
Investigators have not established that the condition, known as myocarditis, was caused by the shots. Most cases have been mild, according to the Centers for Disease Control and Prevention, which continues to strongly urge people to get vaccinated.
“Reported cases appear to be mild and often go away without requiring treatment,” CDC spokesman Benjamin Haynes said. He said that the reports are “rare given the number of vaccine doses administered.”
As of Monday afternoon, nearly 164 million people in the United States had received at least one dose of a coronavirus vaccine, according to the CDC. That is 49.4% of the total population and 61.5% of adults.
The first reports of myocarditis following vaccinations emerged in Israel. Some 62 people, mostly young adults, were diagnosed with the heart inflammation after receiving the Pfizer-BioNTech vaccine, according to the Times of Israel, which cited a leaked report from the Israeli Health Ministry. More than 5 million people in Israel had been vaccinated by that point.
Regulators in Europe said this month that some cases had been reported there as well following vaccination with an mRNA vaccine known as Comirnaty, but they did not attribute the cases to the vaccine. That vaccine has not been authorized in the United States.
The Covid-19 Vaccines Safety Technical Work Group (VaST), a panel of experts that advises the CDC, heard multiple presentations last week about myocarditis and the vaccines, according to a summary posted online by the agency. The CDC said there had been “several dozen” cases in the United States among adolescents and young adults, most of them males, and usually after the second dose of either the Pfizer-BioNTech or Moderna vaccine. Typically the condition is seen about four days after the second dose.
“Within CDC safety monitoring systems, rates of myocarditis reports in the window following COVID-19 vaccination have not differed from expected baseline rates,” the CDC summary stated. “However, [advisory panel] members felt that information about reports of myocarditis should be communicated to providers.”
The vaccine safety panel met again Monday and addressed the issue, according to a person present who was not authorized to disclose the private discussion and spoke on the condition of anonymity.
Public health officials are telling people to continue to seek vaccination, because the health risks posed by covid-19, the disease caused by the virus, exceed those from vaccine side effects, which tend to go away on their own.
But they also urge health care providers to report unusual side effects among their patients.
Such heart muscle inflammation can be caused by viruses themselves, and potentially by the vaccinations, with most people recovering with no long-term effects, said Mitchell Elkind, president of the American Heart Association.
Covid-19 poses a greater threat than mild heart inflammation, even for young people who typically do not become severely ill or die of the disease, Elkind said Monday.
“Most of the time, myocarditis is a transient condition that people recover from without any long-term problems,” he said.
Myocarditis and a similar condition, pericarditis, which is an inflammation of tissue surrounding the heart, can be caused by the coronavirus. It is unclear whether the condition is caused by the virus invading the cells or the immune system’s inflammatory response, Elkind said.
The two vaccines involved in these cases in the United States, from Pfizer and its partner BioNTech, and from Moderna, use an injected scrap of messenger RNA to incite cells to manufacture a protein that matches the structure of the spike protein on the surface of the coronavirus. The vaccines do not contain the coronavirus itself, the heart association noted in a statement released Sunday night.
“The recommendation for vaccination specifically includes people with cardiovascular risk factors such as high blood pressure, obesity and type 2 diabetes, those with heart disease, and heart attack and stroke survivors, because they are at much greater risk of an adverse outcome from the COVID-19 virus than they are from the vaccine,” the association said.
People should be on alert for any of the following symptoms in the weeks following vaccination, the heart association said:
– Chest pain, including sharp, sudden, stabbing pains
– Difficulty breathing
– Abnormal heartbeat
– Severe headache
– Blurry vision
– Fainting
– Weakness or sensory changes
– Confusion or trouble speaking
– Seizures
– Unexplained abdominal pain
– New leg pain or swelling
Published : May 25, 2021
By : The Washington Post · Joel Achenbach, Lena H. Sun
แพทย์เฉพาะทางด้านกระดูกและข้อ กระดูกสันหลัง เผยความไม่สบายและความเจ็บป่วยที่กระดูกและข้อที่เกิดจากการ Work from Home มีอะไรได้บ้าง และเราจะป้องกันได้อย่างไร
ในห้วงเวลาที่ประเทศไทยกำลังเผชิญกับโรค Covid-19 ที่กำลังระบาดในขณะนี้ มีหลายคนต้องปรับตารางการทำงาน เพื่อรองรับกับสถานการณ์การระบาด และจำเป็นต้องทำงานจากที่บ้าน หรือที่เรียกกันว่า Work from Home ซึ่งการที่ต้องเปลี่ยนสถานที่จากที่ทำงานมาเป็นที่บ้านก็มีบางปัจจัยที่อาจทำให้เกิดความไม่สบาย หรือเกิดความเจ็บป่วยของโรคทางกระดูกและข้อได้
Covid-19 ยังไม่จบง่าย ๆ พวกเรายังจำเป็นต้องทำงานจากที่บ้านกันไปอีกสักพัก ดังนั้น เรามาทำให้การ Work from Home เป็นการทำงานที่ดีต่อสุขภาพกันดีกว่า เพียงปฏิบัติตัวให้ถูกต้อง ปรับสภาพแวดล้อมให้เหมาะสม ก็จะทำให้ลดความเครียดจากการทำงาน และมีความสุขมากขึ้น
Many people have been wondering about what they can or cannot consume before they get their Covid-19 shot.
Here’s some advice from the Health Department:
What you CAN take before the shot:
• Prescribed medication for chronic diseases like respiratory disorder, heart and blood vessels, kidney disease, stroke, cancer, diabetes and weight-loss drugs.
• Blood thinners
• Paracetamol (can only be taken after the vaccine for pain)
What you CANNOT take before the shot:
• Cafergot or Relpax for migraine: It will make the heart palpitate, resulting in the contraction of blood vessels and a rise in blood pressure.
• Caffeinated drinks such as tea and coffee: Caffeine will cause the same symptoms as above.
• Non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen, Arcoxia and Celebrex: Taking these drugs after the jab will reduce the efficacy of the vaccine.
Precautions
• Inform the medic if you have a fever before you get your jab
• The second jab should be taken at least a month later
• People with immune system disorders should consult a doctor before getting a jab
• Do not refrain from eating or drinking fluids before the jab
G20 leaders pledge support for Access to Covid-19 Tools Accelerator as crisis grows
World leaders on Saturday met at the Global Health Summit, co-hosted by the European Commission and Italy as part of its G20 presidency, to adopt an agenda to overcome the Covid-19 pandemic, and develop and endorse a Rome Declaration of principles.
The meeting came at a time when the virus is surging and spreading uncontrollably in many parts of the world.
With nine people losing their lives to Covid-19 every minute on average, and as the risk of even more transmissible and dangerous variants increases, the Global Health Summit comes at a critical juncture. The future of the pandemic is in the hands of the G20 leaders.
The Access to Covid-19 Tools Accelerator (ACT-Accelerator) was launched just over a year ago in response to the G20’s call for a global mechanism to accelerate the development of tests, treatments and vaccines and to ensure their equitable distribution.
Hosted by the World Health Organization, the ACT-Accelerator offers the only end-to-end multilateral solution to speeding up an end to the acute phase of the Covid-19 pandemic.
The ACT-Accelerator welcomes the commitments made at the Global Health Summit and will work with countries to operationalise rapidly these pledges, both financial and – crucially – for over 100 million doses of scarce vaccine, the WHO said.
Current financial commitments are reflected in the ACT-Accelerator interactive funding tracker. However, a significant funding gap remains.
Speeding up an end to the pandemic through the ACT-Accelerator would cost less than 1 per cent of what governments are spending on stimulus packages to treat the consequences of the pandemic.
As the economic and social costs of the pandemic continue to escalate, the case for global solidarity grows even stronger.
The Rome Declaration, released at the end of the summit, reaffirmed leaders’ support for the ACT-Accelerator and underlined the necessity to share the financial burden and close the funding gap, in order for the ACT-Accelerator to fulfil its mandate for the equitable allocation and delivery of tests, treatments and vaccines to defeat the pandemic.
The group also emphasised its support for global sharing of vaccine doses approved for emergency use by the WHO and through Covax.
Carl Bildt, special envoy for the ACT-Accelerator and former prime minister of Sweden, said: “Today’s commitments are welcome – but more action is needed now, not in weeks or months, to change the course of the pandemic. While some countries have moved beyond just words, by donating vaccines and pledging to fully finance the ACT-Accelerator, further action is needed from G20 and G7 leaders if we are to stop this virus from spreading and mutating further. We all have substantial work ahead of us.”
People across the world are hoping the vaccines will help reduce fatalities and finally bring the Covid-19 crisis to an end.
Like other countries, Thailand has also been working on inoculating 70 per cent of its population to achieve herd immunity. To get a jab in Thailand, people can either register through the “Mor Phrom” (Doctors Ready) application or at medical facilities nationwide. However, people are still concerned about which brand of vaccine they will get.
As of May 14, the Thai Food and Drug Administration (FDA) had approved four vaccines:
Sinovac
The inactivated vaccine, manufactured by a private Chinese company, was approved by the Thai FDA on February 22.
According to the World Health Organisation, this vaccine effectively protects people below the age of 60.
Dr Nakhon Premsri, director of the National Vaccine Institute, said the vaccine offers 50.7 per cent protection against infection and cuts down the chance of developing moderate symptoms by 83.7 per cent and severe symptoms by 100 per cent. This is a two-dose vaccine.
AstraZeneca
This adenovirus type vaccine, developed jointly by the Swedish firm AstraZeneca and UK’s Oxford University, was approved in Thailand in late January.
This vaccine has been found to offer 54.1 per cent protection against infection and cuts down the chance of developing moderate symptoms by 70.4 per cent and 100 per cent against severe symptoms.
Recent studies show that the vaccine is more effective if the second dose is delivered within an eight to 12-week interval.
Johnson & Johnson
This adenovirus type vaccine was approved by the Thai FDA on March 25.
It offers 66.9 to 85.4 per cent protection against moderate and severe infection through just one dose of the vaccine.
Moderna
This mRNA type vaccine was approved on May 13 and has been categorised as an alternative vaccine that can be procured by the private sector.
Dr Norraphat Pisirikarn, acting director at the Government Pharmaceutical Organisation, said this vaccine can stimulate immunity against Covid-19 3.4 times higher than plasma therapy.
“Fourteen days after the second jab, the vaccine offers 94.1 per cent protection to people below 65 and 86.4 per cent to those older than 65,” Norraphat said. “It reduces the severity of infections and mortality by 100 per cent.”
Recent tests show that it is effective against the UK B117 and South African B1351 mutations, he said.
แพทย์เฉพาะทางด้านกระดูกและข้อ กระดูกสันหลัง เผยความไม่สบายและความเจ็บป่วยที่กระดูกและข้อที่เกิดจากการ Work from Home มีอะไรได้บ้าง และเราจะป้องกันได้อย่างไร
เมื่อต้องอยู่ด้วยกันมากขึ้นช่วง Covid-19 ณ จุดนี้ … Quality Time หรือมะเร็งที่ลุกลามความสัมพันธ์
เปลี่ยนจากผู้เล่นมาเป็นผู้สังเกตการณ์ ฟังสัญญาณเตือนเมื่อร่างกายติดสมาร์ทโฟน เช็กลิสต์เบื้องต้นนั่งหลังค่อมไหล่ห่อ คอยื่น ปวดเมื่อยบ่า ก้านคอ สะบัก นิ้วล็อกมือชา มือไม่มีแรง แม้แต่อาการมึนๆ ตึงๆ ปวดศีรษะ ปวดกระบอกตา ตาพล่ามัว หาวนอนบ่อยๆ หายใจไม่อิ่ม ฯลฯ
ไทยรู้สู้โควิด เผยข้อแนะนำการเตรียมตัวก่อนไปฉีดวัคซีนป้องกันโควิด-19
Preparing for your Covid-19 jab
Covid vaccines approved in Thailand explained
กรมอนามัย กระทรวงสาธารณสุข เผย 7 เมนูให้คุณค่าทางโภชนาการ เสริมสร้างภูมิคุ้มกัน อุดมไปด้วย วิตามินเอ วิตามินซี วิตามินดีและธาตุเหล็ก ที่ช่วยต้านอนุมูลอิสระ เสริมภูมิคุ้มกัน ลดการติดเชื้อในระบบทางเดินหายใจ และลดความเสี่ยงของการติดเชื้อไวรัสโควิด-19
SootinClaimon.Com 